DS-8201a Shows Promise in Treatment of HER2-Positive Breast Cancer

from Oncology Learning Network · host HMP Global

Sherene Loi, MD, PhD, Consultant Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne, Australia, spoke with Oncology Learning Network about data that was presented regarding the use of DS-8201a in the treatment of HER2-positive breast cancer.

Episode metadata supplied by the publisher feed · Published Dec 12, 2019

Embed this episode

Attribution link and audio player

Ready to play

DS-8201a Shows Promise in Treatment of HER2-Positive Breast Cancer

0:00 1:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 1 minute long.

When was this Oncology Learning Network episode published?

This episode was published on December 12, 2019.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!